Alsinnawi, Mazen <br/><br/>
Association of prostate cancer SLCO gene expression with Gleason grade and alterations following androgen deprivation therapy.  [electronic resource] 

 -  Prostate cancer and prostatic diseases  12 2019 
 - 560-568 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1476-5608 
<br/><br/><label>Standard No.: </label>10.1038/s41391-019-0141-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Androgen Antagonists--pharmacology<br/>Androstenes--pharmacology<br/>Dehydroepiandrosterone Sulfate--metabolism<br/>Disease Progression<br/>Docetaxel--pharmacology<br/>Follow-Up Studies<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoplasm Grading<br/>Organic Anion Transporters--metabolism<br/>Prostate--pathology<br/>Prostate-Specific Antigen--blood<br/>Prostatectomy<br/>Prostatic Neoplasms, Castration-Resistant--diagnosis<br/>Solute Carrier Organic Anion Transporter Family Member 1B3--metabolism<br/>Testosterone--metabolism<br/>Treatment Outcome